Medicare Compliance & Reimbursement
Democrats May Have The Wrong Idea About Negotiating Drug Prices, NCPA Claims
Although many industry leaders cheered the Democrats' promise to repeal the legislation that bans Medicare from negotiating drug prices directly with pharmaceutical companies, a new brief finds that this may not actually lower drug prices for Medicare.
What lawmakers are forgetting is that market power will often win out over bargaining power, claims a new issue brief from the National Center for Policy Analysis (NCPA).
Although Medicare is the largest buyer when it comes to prescription drugs, many pharmaceutical companies have patents on their drugs, giving them monopolies on many key drugs, NCPA says. "That means the seller cannot be threatened with replacement by a substitute. Instead, the only threat is that the two sides fail to agree and the drug is withheld from the market."
So if the government's only bargaining power is to say 'no,' this could leave Medicare in a sticky situation. A private plan could walk away from negotiations with a drug company without many problems, but the government would suffer political backlash if it doesn't cover the widest range of drugs for benes, NCPA reasons.
Also, "if the government acts as one large buyer for Medicare, the cost to pharmaceutical companies of granting discounts becomes greater," the brief points out.
Another concern is researchers' findings that since Medicaid's "best-price" rule passed in 1990, drug prices have risen for the private sector, NCPA says.
"Empowering the government to negotiate with pharmaceutical companies is not necessarily equivalent to achieving lower drug prices," NCPA maintains. "In fact, neither economic theory nor historical experience suggests that will be the outcome."
To read the issue brief, go to www.ncpa.org/pub/ba/ba575/ba575.pdf.
Medicare Compliance & Reimbursement
- CODING:
Contact Your Carrier Now To Overturn Denials Of 29999 And Other Codes
You can't use a modifier to override nursing facility edits anymore.
Correct Coding Initiative (CCI) version [...] - THERAPISTS:
Your Raise Is Only $40 -- Now Experts Weigh In On What Will Affect You Most
CMS offers 3 key changes to the therapy cap for outpatients.
The therapy cap will go [...] - DOCUMENTATION:
Find Out What Therapy Documentation Practices You'll Need To Start Now
Catch some major documentation clarifications -- CMS spells them out.
In addition to sending out a [...] - SNFs:
The Way Your Rehab RUGs Shake Out In Your Facility Can Lead To A Shake Up With Your FI
Identify rehab RUG patterns that shout 'come audit me.'
You need to identify RUG profiles that [...] - MEDICARE PART D:
Democrats May Have The Wrong Idea About Negotiating Drug Prices, NCPA Claims
Why repealing the ban could be useless for Part D.
Although many industry leaders cheered the [...] - PHYSICIANS:
Why You Can't Use A Modifier To Override SRS Edits
New anesthesia, stereotactic radiosurgery codes on CCI's hit list.
CPT 2007 brings a number of new [...] - INDUSTRY NOTES:
You Can Breathe A Sigh Of Relief--Congress Extends Therapy Cap Exceptions Process
Plus: PTPN selects FOTO system to track patient progress.
Congress passed H.R. 6111, the Tax Relief [...]
